無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インスリンデリバリーデバイスの世界市場の予測 〜2021年:インスリンペン・インスリンポンプ・注射針・インスリンシリンジ

Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 494471
出版日 ページ情報 英文 151 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
インスリンデリバリーデバイスの世界市場の予測 〜2021年:インスリンペン・インスリンポンプ・注射針・インスリンシリンジ Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021
出版日: 2017年04月24日 ページ情報: 英文 151 Pages
概要

世界のインスリンデリバリーデバイスの市場は予測期間中、9.1%のCAGR (年間複合成長率) で推移し、2016年の115億4000万米ドルから、2021年には178億5000万米ドルの規模に成長すると予測されています。主要国での有利な償還シナリオや強力な政府によるサポート、技術的発展、糖尿病人口の増加、製品への認知度の拡大などの要因が同市場の成長を推進しています。

当レポートでは、世界のインスリンデリバリーデバイスの市場を調査し、市場および製品の定義と概要、市場成長への各種影響因子および市場機会の分析、製品タイプ・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

FIGURE 9 INSULIN DELIVERY DEVICES MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 市場実績:地域・タイプ別
  • 市場実績・予測:エンドユーザー別
  • 地域概要

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 課題

第6章 市場分析:タイプ別

  • イントロダクション
  • ペン
    • 再利用可能インスリンペン
    • ディスポーザブルインスリンペン
  • インスリンポンプ
    • 外付け/テザード型
    • パッチ型
  • ペン注射針
    • スタンダード型
    • セーフティ型
  • インスリンシリンジ
  • その他

第7章 市場分析:エンドユーザー別

  • イントロダクション
  • 患者自身/在宅ケア
  • 病院・診療所

第8章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他
  • アジア太平洋
  • その他の地域

第9章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向
    • マーケティング&プロモーション
    • 合意・提携・JV・協力
    • 製品の投入
    • 拡張
    • その他

第10章 企業プロファイル

  • BECTON, DICKINSON AND COMPANY
  • NOVO NORDISK A/S
  • MEDTRONIC PLC
  • SANOFI
  • ELI LILLY AND COMPANY
  • YPSOMED HOLDING AG
  • ANIMAS CORPORATION (JOHNSON AND JOHNSON)
  • TANDEM DIABETES CARE, INC.
  • INSULET CORPORATION
  • BIOCON LIMITED

第11章 付録

図表

目次
Product Code: MD 5192

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021).

Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic population, and rising awareness about insulin delivery devices are the major factors driving the growth of this market. However, needle anxiety, emergence of oral drug delivery methods, and the growing trend of reuse of pen needles and infusion sets are the major factors restraining the growth of this market. Furthermore, increasing research and development activities and increasing diabetes-related health expenditure in emerging countries are likely to offer significant growth opportunities for players operating in the market.

The global insulin delivery devices market is segmented on the basis of type, end user, and region. In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is projected to have the highest growth rate in the forecast period. Factors such as rising prevalence of diabetes, high adoption of insulin pens, and government initiatives in Singapore are expected to support the growth of the Asia-Pacific insulin delivery devices market.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, collaborations, agreements, partnerships, alliances, grants, joint ventures, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the insulin delivery devices market.

  • By Company Type: Tier 1: 70%, Tier 2: 22%, Tier 3: 8%
  • By Designation: Director Level: 65%, C-level: 25%, Others: 10%
  • By Region: North America: 55%, Europe: 20%, APAC: 20%, RoW: 5%

Key players in the global insulin delivery devices market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.).

Research Coverage:

This report studies the insulin delivery devices market based on type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one, or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the types of insulin delivery devices offered by top players in the insulin delivery devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the insulin delivery devices market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for insulin delivery devices across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the insulin delivery devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the insulin delivery devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. INSULIN DELIVERY DEVICES: MARKET SNAPSHOT
  • 4.2. GEOGRAPHIC ANALYSIS: INSULIN DELIVERY DEVICES MARKET, BY TYPE (2016)
  • 4.3. INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2016 VS. 2021(USD BILLION)
  • 4.4. GEOGRAPHIC SNAPSHOT OF THE INSULIN DELIVERY DEVICES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing diabetic population
      • 5.2.1.2. Technological advancements in insulin delivery devices
      • 5.2.1.3. Favorable reimbursement environment and government support in selected countries
      • 5.2.1.4. Conferences, Meetings, and Congresses to create awareness about Insulin delivery devices
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Poor reimbursement structure in developing countries
      • 5.2.2.2. Needle anxiety in patients to affect the growth of the pen needles and syringes market
      • 5.2.2.3. Oral insulin as an alternative drug delivery method
      • 5.2.2.4. Issues associated with the reuse of pen needles and infusion sets
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing research and development activities
      • 5.2.3.2. Increasing diabetes-related health expenditure in emerging economies
      • 5.2.3.3. Safety needles
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Severe shortage of endocrinologists in the U.S.

6. INSULIN DELIVERY DEVICES MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. PENS
    • 6.2.1. REUSABLE INSULIN PENS
    • 6.2.2. DISPOSABLE INSULIN PENS
  • 6.3. INSULIN PUMPS
    • 6.3.1. EXTERNAL/TETHERED PUMPS
    • 6.3.2. PATCH PUMPS
  • 6.4. PEN NEEDLES
    • 6.4.1. STANDARD PEN NEEDLES
    • 6.4.2. SAFETY PEN NEEDLES
  • 6.5. INSULIN SYRINGES
  • 6.6. OTHER INSULIN DELIVERY DEVICES

7. INSULIN DELIVERY DEVICES MARKET, BY END USER

  • 7.1. INTRODUCTION
  • 7.2. PATIENTS/HOMECARE
  • 7.3. HOSPITALS & CLINICS

8. INSULIN DELIVERY DEVICES MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
      • 8.2.1.1. Rising prevalence of diabetes and favorable reimbursement scenario
      • 8.2.1.2. Awareness activities to stimulate usage of insulin delivery devices in the U.S.
      • 8.2.1.3. Growing venture capital investments and issuance of IPOs
      • 8.2.1.4. FDA approvals to increase the commercial availability of insulin delivery devices
    • 8.2.2. CANADA
      • 8.2.2.1. High prevalence of diabetes and favorable reimbursement for insulin delivery devices
      • 8.2.2.2. Regulations for the usage of safety-engineered needles
  • 8.3. EUROPE
      • 8.3.1.1. EU's directive on the prevention of sharps injuries in hospitals and the healthcare sector
    • 8.3.2. GERMANY
      • 8.3.2.1. High prevalence of diabetes, favorable reimbursement for insulin devices
    • 8.3.3. FRANCE
      • 8.3.3.1. High insurance coverage and increasing affordability
      • 8.3.3.2. Conferences and exhibitions
    • 8.3.4. U.K.
      • 8.3.4.1. Role of diabetes U.K. in research and diabetes care
      • 8.3.4.2. Low insulin pump penetration in the U.K.
    • 8.3.5. REST OF EUROPE (ROE)
      • 8.3.5.1. Spain: Regulations for mandatory use of safety needles, large diabetic population
      • 8.3.5.2. Italy: Regional variations in terms of coverage and benefits to hinder market growth
      • 8.3.5.3. Strong presence of major insulin delivery device manufacturers in ROE countries
      • 8.3.5.4. Large diabetic populations in Russia, Romania, Poland, and Portugal
  • 8.4. ASIA- PACIFIC
      • 8.4.1.1. High diabetes incidence and population in Asia-Pacific
      • 8.4.1.2. Partnerships among global and local players in Asia-Pacific
      • 8.4.1.3. Japan: High adoption of insulin pens and approval of injectable insulin
      • 8.4.1.4. India: Low penetration of pen needles & pumps and low awareness to restrain market growth
      • 8.4.1.5. Government initiatives in Singapore
      • 8.4.1.6. Vietnam, a potential market for insulin delivery devices
      • 8.4.1.7. Australia: Amendments in NDSS to broaden patient access to diabetes products
  • 8.5. ROW
      • 8.5.1.1. Increasing diabetic population
      • 8.5.1.2. Rising awareness on diabetes
      • 8.5.1.3. Conferences

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. MARKET SHARE ANALYSIS
  • 9.3. COMPETITIVE SITUATION AND TRENDS
    • 9.3.1. MARKETING AND PROMOTION
    • 9.3.2. AGREEMENTS, ALLIANCES, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS
    • 9.3.3. PRODUCT LAUNCHES
    • 9.3.4. EXPANSIONS
    • 9.3.5. OTHER STRATEGIES

10. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 10.1. INTRODUCTION
  • 10.2. BECTON, DICKINSON AND COMPANY
  • 10.3. NOVO NORDISK A/S
  • 10.4. MEDTRONIC PLC
  • 10.5. SANOFI
  • 10.6. ELI LILLY AND COMPANY
  • 10.7. YPSOMED HOLDING AG
  • 10.8. ANIMAS CORPORATION (JOHNSON AND JOHNSON)
  • 10.9. TANDEM DIABETES CARE, INC.
  • 10.10. INSULET CORPORATION
  • 10.11. BIOCON LIMITED

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. DISCUSSION GUIDE
  • 11.2. OTHER DEVELOPMENTS
  • 11.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.5. AVAILABLE CUSTOMIZATIONS
  • 11.6. RELATED REPORTS
  • 11.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: 10 COUNTRIES/TERRITORIES WITH THE HIGHEST NUMBER OF DIABETICS (20-79 YEARS), 2015 & 2040
  • TABLE 2: FDA APPROVALS IN THE INSULIN DELIVERY DEVICES MARKET (2014-2016)
  • TABLE 3: CONFERENCES, MEETINGS, AND CONGRESSES FOCUSING ON INSULIN DELIVERY DEVICES (2014-2017)
  • TABLE 4: GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 6: PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 7: PENS MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 8: PENS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: PENS MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 10: REUSABLE INSULIN PENS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: REUSABLE INSULIN PENS MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 12: DISPOSABLE INSULIN PENS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: DISPOSABLE INSULIN PENS MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 14: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 15: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 16: INSULIN PUMPS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: INSULIN PUMPS MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 18: EXTERNAL/TETHERED PUMPS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: EXTERNAL/TETHERED PUMPS MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 20: PATCH PUMPS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: PATCH PUMPS MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 22: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 23: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 24: PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 26: STANDARD PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: STANDARD PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 28: SAFETY PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: SAFETY PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 30: INSULIN SYRINGES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: INSULIN SYRINGES MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS) 58  
  • TABLE 32: OTHER INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: OTHER INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (THOUSAND UNITS)
  • TABLE 34: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 35: PATIENTS/HOMECARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 44: INVESTEMENTS MADE BY COMPANIES FOR DIABETES MANAGEMENT, 2015
  • TABLE 45: FDA APPROVALS FOR INSULIN DELIVERY DEVICES (2013-2016)
  • TABLE 46: U.S.: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: U.S.: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: U.S.: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: U.S.: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: U.S.: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 51: ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES IN CANADA FOR TYPE I DIABETES, MARCH 2015
  • TABLE 52: CANADA: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: CANADA: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: CANADA: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: CANADA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: CANADA: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: EUROPE: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: EUROPE: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 79  
  • TABLE 62: EUROPE: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 63: GERMANY: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: GERMANY: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: GERMANY: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: GERMANY: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: GERMANY: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 68: FRANCE: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: FRANCE: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: FRANCE: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: FRANCE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: FRANCE: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 73: U.K.: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: U.K.: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: U.K.: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: U.K.: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: U.K.: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 78: INDICATIVE LIST: COMPANIES HEADQUARTERED IN ROE COUNTRIES
  • TABLE 79: ROE: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: ROE: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: ROE: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: ROE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: ROE: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 84: DIABETES PREVALENCE IN ASIA-PACIFIC, BY COUNTRY
  • TABLE 85: ASIA-PACIFIC: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: ASIA-PACIFIC: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 87: ASIA-PACIFIC: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: ASIA-PACIFIC: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 89: ASIA-PACIFIC: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 90: CONFERENCE IN AFRICA, BRAZIL, AND THE MIDDLE EAST (2015-2017)
  • TABLE 91: ROW: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: ROW: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: ROW: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: ROW: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: ROW: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 101  
  • TABLE 96: MARKETING AND PROMOTION: RECENT DEVELOPMENTS (2014-2017)
  • TABLE 97: AGREEMENTS, ALLIANCES, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS: RECENT DEVELOPMENTS (2014-2017)
  • TABLE 98: PRODUCT LAUNCHES: RECENT DEVELOPMENTS (2014-2017)
  • TABLE 99: EXPANSIONS: RECENT DEVELOPMENTS (2014-2017)
  • TABLE 100: OTHER STRATEGIES: RECENT DEVELOPMENTS (2014-2017)

LIST OF FIGURES

  • FIGURE 1: GLOBAL INSULIN DELIVERY DEVICES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 4: RESEARCH DESIGN
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: INSULIN PENS SEGMENT COMMANDED THE LARGEST SHARE OF THE INSULIN DELIVERY DEVICES MARKET IN 2016
  • FIGURE 7: PATIENTS/HOMECARE SEGMENT TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 8: NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE INSULIN DELIVERY DEVICES MARKET IN 2016
  • FIGURE 9: ASIA-PACIFIC OFFERS SIGNIFICANT GROWTH OPPORTUNITIES FOR PLAYERS IN THE INSULIN DELIVERY DEVICES MARKET
  • FIGURE 10: INSULIN PENS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 11: PATIENTS/HOMECARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE INSULIN DELIVERY DEVICES MARKET IN 2016
  • FIGURE 12: ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD (2016-2021)
  • FIGURE 13: INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14: PENS COMMANDED THE LARGEST SHARE IN INSULIN DELIVERY DEVICES MARKET IN 2016
  • FIGURE 15: PATIENTS/HOMECARE SEGMENT TO COMMAND THE LARGEST SHARE OF THE INSULIN DELIVERY DEVICES END-USER MARKET
  • FIGURE 16: NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
  • FIGURE 17: EUROPE: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
  • FIGURE 18: DIABETES U.K.: FUNDS RAISED VS. FUNDS INVESTED
  • FIGURE 19: COMPARISON OF DIABETES CASES, RELATED DEATHS IN EUROPEAN COUNTRIES, 2015
  • FIGURE 20: ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SNAPSHOT
  • FIGURE 21: ROW INSULIN DELIVERY DEVICES MARKET SNAPSHOT
  • FIGURE 22: GROWTH STRATEGIES, BY COMPANY
  • FIGURE 23: MARKET SHARE ANALYSIS FOR INSULIN PENS, BY KEY PLAYER, 2015
  • FIGURE 24: MARKET SHARE ANALYSIS FOR INSULIN PUMPS, BY KEY PLAYER, 2015
  • FIGURE 25: MARKET SHARE ANALYSIS FOR PEN NEEDLES, BY KEY PLAYER, 2015
  • FIGURE 26: MARKET SHARE ANALYSIS FOR SYRINGES, BY KEY PLAYER, 2015
  • FIGURE 27: COMPANIES ADOPTED MARKETING & PROMOTION AS KEY GROWTH STRATEGY FROM 2013 TO 2016
  • FIGURE 28: GEOGRAPHIC ASSESSMENT OF PLAYERS IN THE INSULIN DELIVERY DEVICES MARKET
  • FIGURE 29: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 30: NOVO NORDISK A/S: COMPANY SNAPSHOT (2016)
  • FIGURE 31: MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 32: SANOFI: COMPANY SNAPSHOT (2016)
  • FIGURE 33: ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 34: YPSOMED HOLDING AG: COMPANY SNAPSHOT (2015)
  • FIGURE 35: JOHNSON AND JOHNSON: COMPANY SNAPSHOT (2016)
  • FIGURE 36: TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 37: INSULET CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 38: BIOCON, LTD.: COMPANY SNAPSHOT (2015)
Back to Top